Top Stories
-
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
-
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
-
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
-
Columbia oncologists are bringing their latest techniques in precision medicine to veterans with advanced prostate cancer.
Latest News
- October 12, 2015
Andrea Califano and his investigative team discover a molecular signaling mechanism underlying a specific type of highly aggressive breast cancer.
Topic
- October 5, 2015
KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, helping the immune system to help detect and fight cancer cells.
Topic
- September 23, 2015
The Columbia Combined Cancer Panel has been granted full approval by the New York State Department of Health.
Topic
- September 18, 2015
Dr. Naiyer Rizvi, director of thoracic oncology at CUMC, offers updates on immune checkpoint inhibitors in certain forms of lung cancers.
Topic
- May 26, 2015
Columbia scientists have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out.
- April 14, 2015
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
- March 26, 2015
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Topic
- March 19, 2015
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
Topic
- March 16, 2015
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
Topic
